{"DataElement":{"publicId":"5097023","version":"1","preferredName":"Human Papillomavirus Enzyme-linked Immunosorbent Spot Assay Type","preferredDefinition":"Type of ELISPOT HPV assay that was performed.","longName":"4119877v1.0:5097016v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"4119877","version":"1","preferredName":"Enzyme-linked Immunosorbent Spot Assay Result","preferredDefinition":"A highly sensitive immunoassay capable of detecting secreted materials from individual cells upon activation. If the material of interest is secreted in response to a particular stimulus, then the material will bind to a specific immobilized antibody. Binding is then verified and visualized by applying other antibodies that have been tagged in some way._The result of an action.","longName":"4119875v1.0:2177339v1.0","context":"DCI","contextVersion":"1","ObjectClass":{"publicId":"4119875","version":"1","preferredName":"Enzyme-linked Immunosorbent Spot Assay","preferredDefinition":"A highly sensitive immunoassay capable of detecting secreted materials from individual cells upon activation. If the material of interest is secreted in response to a particular stimulus, then the material will bind to a specific immobilized antibody. Binding is then verified and visualized by applying other antibodies that have been tagged in some way.","longName":"C102632","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Enzyme-linked Immunosorbent Spot Assay","conceptCode":"C102632","definition":"A highly sensitive immunoassay capable of detecting secreted materials from individual cells upon activation. If the material of interest is secreted in response to a particular stimulus, then the material will bind to a specific immobilized antibody. Binding is then verified and visualized by applying other antibodies that have been tagged in some way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F12137BF-B8CF-6257-E040-BB89AD434C83","latestVersionIndicator":"Yes","beginDate":"2014-01-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-29","modifiedBy":"ONEDATA","dateModified":"2014-01-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177339","version":"1","preferredName":"Result","preferredDefinition":"Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"Result","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-528F-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F12137BF-B8DD-6257-E040-BB89AD434C83","latestVersionIndicator":"Yes","beginDate":"2014-01-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-01-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5097016","version":"1","preferredName":"Human Papillomavirus Enzyme-linked Immunosorbent Spot Assay Type","preferredDefinition":"Related to the specific type of ELISPOT performed","longName":"5097016v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"HPV 52 E6","valueDescription":"Papillomavirus Transforming Protein E6 Human Papillomavirus-52","ValueMeaning":{"publicId":"5097017","version":"1","preferredName":"Papillomavirus Transforming Protein E6 Human Papillomavirus-52","longName":"5097017","preferredDefinition":"Binds to and promotes degradation of p53 protein resulting in disruption of cell cycle regulation.: A virus comprised of a protein coat (capsid) surrounding a circular, double-stranded DNA organized into coding and non-coding regions, which can induce epithelial lesions. Infection with human papillomavirus-52 is associated with a high risk for cervical intraepithelial neoplasia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillomavirus Transforming Protein E6","conceptCode":"C19170","definition":"Binds to and promotes degradation of p53 protein resulting in disruption of cell cycle regulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Human Papillomavirus-52","conceptCode":"C103001","definition":"A virus comprised of a protein coat (capsid) surrounding a circular, double-stranded DNA organized into coding and non-coding regions, which can induce epithelial lesions. Infection with human papillomavirus-52 is associated with a high risk for cervical intraepithelial neoplasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28AF609C-519C-C890-E050-BB89AD437C1A","latestVersionIndicator":"Yes","beginDate":"2016-01-06","endDate":null,"createdBy":"RODGERSC","dateCreated":"2016-01-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"28AF609C-51B5-C890-E050-BB89AD437C1A","beginDate":"2016-01-06","endDate":null,"createdBy":"RODGERSC","dateCreated":"2016-01-06","modifiedBy":"ONEDATA","dateModified":"2016-01-06","deletedIndicator":"No"},{"value":"HPV 35 E6","valueDescription":"Papillomavirus Transforming Protein E6 Human Papillomavirus-35","ValueMeaning":{"publicId":"5097018","version":"1","preferredName":"Papillomavirus Transforming Protein E6 Human Papillomavirus-35","longName":"5097018","preferredDefinition":"Binds to and promotes degradation of p53 protein resulting in disruption of cell cycle regulation.: A virus comprised of a protein coat (capsid) surrounding a circular, double-stranded DNA organized into coding and non-coding regions, which can induce epithelial lesions. Infection with human papillomavirus-35 is associated with a high risk for cervical intraepithelial neoplasia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillomavirus Transforming Protein E6","conceptCode":"C19170","definition":"Binds to and promotes degradation of p53 protein resulting in disruption of cell cycle regulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Human Papillomavirus-35","conceptCode":"C102997","definition":"A virus comprised of a protein coat (capsid) surrounding a circular, double-stranded DNA organized into coding and non-coding regions, which can induce epithelial lesions. Infection with human papillomavirus-35 is associated with a high risk for cervical intraepithelial neoplasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28AF609C-51C2-C890-E050-BB89AD437C1A","latestVersionIndicator":"Yes","beginDate":"2016-01-06","endDate":null,"createdBy":"RODGERSC","dateCreated":"2016-01-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"28AF609C-51DB-C890-E050-BB89AD437C1A","beginDate":"2016-01-06","endDate":null,"createdBy":"RODGERSC","dateCreated":"2016-01-06","modifiedBy":"ONEDATA","dateModified":"2016-01-06","deletedIndicator":"No"},{"value":"HPV 16 E7","valueDescription":"Papillomavirus Transforming Protein E7 Human Papillomavirus-16","ValueMeaning":{"publicId":"5097020","version":"1","preferredName":"Papillomavirus Transforming Protein E7 Human Papillomavirus-16","longName":"5097020","preferredDefinition":"Complexes with and inactivates Rb protein resulting in disruption of cell cycle regulation.: A virus comprised of a protein coat (capsid) surrounding a circular, double-stranded DNA organized into coding and non-coding regions, which can induce skin and mucosal epithelial lesions. Human papillomavirus-16 (HPV16) has been directly linked to cervical cancer and is significantly associated with invasiveness. Progression from low- to high-grade neoplasia is often associated with the integration of the HPV16 genome into the host chromosome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillomavirus Transforming Protein E7","conceptCode":"C19171","definition":"Complexes with and inactivates Rb protein resulting in disruption of cell cycle regulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Human Papillomavirus-16","conceptCode":"C14338","definition":"A virus comprised of a protein coat (capsid) surrounding a circular, double-stranded DNA organized into coding and non-coding regions, which can induce skin and mucosal epithelial lesions. Human papillomavirus-16 (HPV16) has been directly linked to cervical cancer and is significantly associated with invasiveness. Progression from low- to high-grade neoplasia is often associated with the integration of the HPV16 genome into the host chromosome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28AF609C-51E9-C890-E050-BB89AD437C1A","latestVersionIndicator":"Yes","beginDate":"2016-01-06","endDate":null,"createdBy":"RODGERSC","dateCreated":"2016-01-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"28AF609C-5202-C890-E050-BB89AD437C1A","beginDate":"2016-01-06","endDate":null,"createdBy":"RODGERSC","dateCreated":"2016-01-06","modifiedBy":"ONEDATA","dateModified":"2016-01-06","deletedIndicator":"No"},{"value":"HPV 16 E6","valueDescription":"Papillomavirus Transforming Protein E6 Human Papillomavirus-16","ValueMeaning":{"publicId":"5097021","version":"1","preferredName":"Papillomavirus Transforming Protein E6 Human Papillomavirus-16","longName":"5097021","preferredDefinition":"Binds to and promotes degradation of p53 protein resulting in disruption of cell cycle regulation.: A virus comprised of a protein coat (capsid) surrounding a circular, double-stranded DNA organized into coding and non-coding regions, which can induce skin and mucosal epithelial lesions. Human papillomavirus-16 (HPV16) has been directly linked to cervical cancer and is significantly associated with invasiveness. Progression from low- to high-grade neoplasia is often associated with the integration of the HPV16 genome into the host chromosome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillomavirus Transforming Protein E6","conceptCode":"C19170","definition":"Binds to and promotes degradation of p53 protein resulting in disruption of cell cycle regulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Human Papillomavirus-16","conceptCode":"C14338","definition":"A virus comprised of a protein coat (capsid) surrounding a circular, double-stranded DNA organized into coding and non-coding regions, which can induce skin and mucosal epithelial lesions. Human papillomavirus-16 (HPV16) has been directly linked to cervical cancer and is significantly associated with invasiveness. Progression from low- to high-grade neoplasia is often associated with the integration of the HPV16 genome into the host chromosome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28AF609C-520F-C890-E050-BB89AD437C1A","latestVersionIndicator":"Yes","beginDate":"2016-01-06","endDate":null,"createdBy":"RODGERSC","dateCreated":"2016-01-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"28AF609C-5228-C890-E050-BB89AD437C1A","beginDate":"2009-11-09","endDate":null,"createdBy":"RODGERSC","dateCreated":"2016-01-06","modifiedBy":"ONEDATA","dateModified":"2016-01-06","deletedIndicator":"No"},{"value":"HPV 18 E6","valueDescription":"Papillomavirus Transforming Protein E6 Human Papillomavirus-18","ValueMeaning":{"publicId":"5097022","version":"1","preferredName":"Papillomavirus Transforming Protein E6 Human Papillomavirus-18","longName":"5097022","preferredDefinition":"Binds to and promotes degradation of p53 protein resulting in disruption of cell cycle regulation.: A virus comprised of a protein coat (capsid) surrounding a circular, double-stranded DNA organized into coding and non-coding regions, which can induce skin and mucosal epithelial lesions. Human papillomavirus-18 (HPV18) has been directly linked to cervical cancer and plays a role in the pathogenesis of the disease. The virus integrates its DNA at specific chromosomal locations, such as 8q24 and 12q15. The use of molecular markers for HPV18 infection may allow the identification of patients with early stage cervical cancer and those at high risk for disease recurrence.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillomavirus Transforming Protein E6","conceptCode":"C19170","definition":"Binds to and promotes degradation of p53 protein resulting in disruption of cell cycle regulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Human Papillomavirus-18","conceptCode":"C14377","definition":"A virus comprised of a protein coat (capsid) surrounding a circular, double-stranded DNA organized into coding and non-coding regions, which can induce skin and mucosal epithelial lesions. Human papillomavirus-18 (HPV18) has been directly linked to cervical cancer and plays a role in the pathogenesis of the disease. The virus integrates its DNA at specific chromosomal locations, such as 8q24 and 12q15. The use of molecular markers for HPV18 infection may allow the identification of patients with early stage cervical cancer and those at high risk for disease recurrence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28AF609C-5235-C890-E050-BB89AD437C1A","latestVersionIndicator":"Yes","beginDate":"2016-01-06","endDate":null,"createdBy":"RODGERSC","dateCreated":"2016-01-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"28AF609C-524E-C890-E050-BB89AD437C1A","beginDate":"2009-11-09","endDate":null,"createdBy":"RODGERSC","dateCreated":"2016-01-06","modifiedBy":"ONEDATA","dateModified":"2016-01-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5097015","version":"1","preferredName":"Human Papillomavirus Enzyme-linked Immunosorbent Spot Assay Type","preferredDefinition":"A strain of papillomavirus that can infect the skin and mucous membranes of humans.:A highly sensitive immunoassay capable of detecting secreted materials from individual cells upon activation. If the material of interest is secreted in response to a particular stimulus, then the material will bind to a specific immobilized antibody. Binding is then verified and visualized by applying other antibodies that have been tagged in some way.:Something distinguishable as an identifiable class based on common qualities.","longName":"C14226:C102632:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Papillomavirus","conceptCode":"C14226","definition":"A strain of papillomavirus that can infect the skin and mucous membranes of humans.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Enzyme-linked Immunosorbent Spot Assay","conceptCode":"C102632","definition":"A highly sensitive immunoassay capable of detecting secreted materials from individual cells upon activation. If the material of interest is secreted in response to a particular stimulus, then the material will bind to a specific immobilized antibody. Binding is then verified and visualized by applying other antibodies that have been tagged in some way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28AF609C-5173-C890-E050-BB89AD437C1A","latestVersionIndicator":"Yes","beginDate":"2016-01-06","endDate":null,"createdBy":"RODGERSC","dateCreated":"2016-01-06","modifiedBy":"ONEDATA","dateModified":"2016-01-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28AF609C-5184-C890-E050-BB89AD437C1A","latestVersionIndicator":"Yes","beginDate":"2016-01-06","endDate":null,"createdBy":"RODGERSC","dateCreated":"2016-01-06","modifiedBy":"MAESKEB","dateModified":"2022-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3029677","version":"1","longName":"UAMS Clinical Research","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812848","version":"1","longName":"UAMS New CDEs","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Which assays were performed:","type":"Preferred Question Text","description":"Which assays were performed:","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28AF86F0-8189-087D-E050-BB89AD436321","latestVersionIndicator":"Yes","beginDate":"2016-01-06","endDate":null,"createdBy":"RODGERSC","dateCreated":"2016-01-06","modifiedBy":"MAESKEB","dateModified":"2021-03-11","changeDescription":"Created for UAMS 1/6/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}